Alopecia Areata Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with breast cancer.
- People whose planned chemotherapy treatment is the Doxorubicin-Cyclophosphamide protocol.
- People who are willing to take part in the study.
- People who are 18 years of age or older.
- People who are women.
Who may not be able to join:
- People who have a health problem or disability that makes communication difficult, such as vision or hearing problems, or neurological or psychiatric conditions.
- People whose breast cancer treatment plan includes treatments other than the Doxorubicin-Cyclophosphamide chemotherapy protocol.
- People who do not wish to take part in the study.
- People who have previously had a disease or skin condition that caused hair loss.
- People who have received chemotherapy before.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +905533228416
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
National Cancer Instute (NCI) Common Terminology Criteria for Adverse Events (CTCAE); Alopecia
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.